EAF2 anticorps (AA 210-260)
-
- Antigène Voir toutes EAF2 Anticorps
- EAF2 (ELL Associated Factor 2 (EAF2))
-
Épitope
- AA 210-260
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp EAF2 est non-conjugé
-
Application
- Immunoprecipitation (IP), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))
- Fonction
- Rabbit anti-EAF2 Antibody, Affinity Purified
- Purification
- Affinity Purified
- Immunogène
- between AA 210 and 260
- Isotype
- IgG
- Top Product
- Discover our top product EAF2 Anticorps primaire
-
-
- Indications d'application
-
IHC: 1:500 - 1:2,000. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.
IP: 2 - 5 μg/mg lysate
WB: Not recommended. A302-503A has not performed satisfactorily when used for WB of EAF2 in crude preparations (e.g. whole cell lysate). This antibody can be used for WB of enriched (e.g. immunoprecipitated) sources of EAF2.
- Restrictions
- For Research Use only
-
- Concentration
- 1000 μg/mL
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C
- Date de péremption
- 12 months
-
- Antigène
- EAF2 (ELL Associated Factor 2 (EAF2))
- Autre désignation
- EAF2 (EAF2 Produits)
- Synonymes
- anticorps eaf2, anticorps MGC69052, anticorps MGC68453, anticorps zgc:86600, anticorps wu:fb76c01, anticorps wu:fc43g12, anticorps BM040, anticorps TRAITS, anticorps U19, anticorps AW048865, anticorps FESTA-L, anticorps FESTA-S, anticorps Festa, anticorps Traits, anticorps ELL associated factor 2 S homeolog, anticorps ELL associated factor 2 L homeolog, anticorps ELL associated factor 2, anticorps eaf2.S, anticorps eaf2.L, anticorps eaf2, anticorps EAF2, anticorps Eaf2
- Sujet
- Background: ELL-associated factor 2 (EAF2) acts as a transcriptional transactivator of TCEA1 elongation activity. It is also a transcriptional transactivator of ELL (eleven nineteen lysine-rich leukemia) 1 and ELL2 elongation activities. EAF2 has been shown to be a potent inducer of apoptosis in prostatic and non-prostatic cell lines and to inhibit prostate tumor growth in vivo [taken from the Universal Protein Resource (UniProt) Q96CJ1].
- ID gène
- 55840
- NCBI Accession
- NP_060926
- UniProt
- Q96CJ1
-